Posttranscriptional regulation of the biosynthesis of connexins, the building blocks of gap junctional channels, may occur by modulation of connexin mRNA stability and translation. To date, few RNA binding proteins and micro-RNAs (miRNAs) affecting connexin expression are known. In recent years, it has become clear that epigenetic processes are also essentially involved in connexin gene expression. In this review, we summarize recent knowledge on regulation of connexin expression by transcription factors and epigenetic mechanisms including microRNA.
The term 'glioma' comprises the majority of malignancies of the central nervous system and encompasses all tumors that are thought to be of glial cell origin. These include astrocytomas, oligodendrogliomas, ependymomas and mixed gliomas. Among them astrocytomas are the most frequent in adults and have been traditionally classified by the World Health Organization (WHO) into four histological grades [1] . More recently, a gene expression-based molecular classical and Mesenchymal subtype has been proposed [2] . Unfortunately, high-grade gliomas (WHO grade III and IV tumors) are the most common type of glioma in adults [3] . Glioblastomas are rapidly progressive, very aggressive, diffusely infiltrate the adjacent brain tissue and are one of the most incurable forms of cancer in humans. Despite significant advances in diagnostics and therapeutics over the past decades, prognosis for patients with glioblastoma remains dismal, with a median survival of 16-19 months [4] , which indicates that a great research effort is required to propose new therapeutic strategies against this devastating disease.
A wide range of molecular alterations has been described in astrocytomas and includes genetic, epigenetic, transcriptomic and microRNA (miRNA) changes. In this review, we will focus on the alterations found in connexin43 (Cx43), an integral membrane protein encoded by GJA1 gene. Cx43 is the most abundant connexin in mammals, widely expressed in different tissues, including the central nervous system, where Cx43 is strongly expressed in astrocytes is strongly expressed in astrocytes [5] . It is well known that Cx43 assembles to form gap junction channels and hemichannels which are contribute to the interchange of molecules between the cells and their extracellular medium [6] . Thus, Cx43 is highly expressed in astrocytes but this expression is downregulated when these cells acquire a malignant phenotype. It is well described that the levels of
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Cx43 protein inversely correlate with the degree of malignancy in astrocytomas. In fact, the levels of Cx43 protein in the vast majority of glioblastomas are negligible [7] .
The half-life of Cx43 is only in the range of 1 to 3 h [8] . In addition to connexin internalization and lysosomal or proteasomal degradation, changes in connexin expression can therefore rapidly alter connexin levels. For excellent summaries on transcriptional and epigenetic control of connexin biosynthesis, the reader is referred to recent review articles [9] . This overview will focus on post-transcriptional processes involved in regulation of connexin expression.
"microRNAs
(miRNAs) are ~ 22-nucleotide single-stranded RNAs that inhibit the expression of specific mRNA targets through Watson-Crick base pairing between the miRNA 'seed region' and sequences commonly located in the 3'-untranslated regions (UTRs)" [10] . The potential roles of miRNAs in controlling connexin expression have recently been investigated [11] .
In recent years the role of miRNAs in cancer has been demonstrated in many types of tumors including glioblastomas where they can control processes such as proliferation, invasion, angiogenesis and apoptosis [12] . Interestingly, some miRNAs involved in gliomagenesis downregulate Cx43 expression. This is the case of mRNA-125b that binds to the Cx43 3'-UTR to down-regulate Cx43 expression and promotes glioma cell-line growth, clone formation and inhibits apoptosis in vitro. The overexpression of Cx43 could counteract the effects of miRNA-125b tumorigenic effect [13] . Other miRNAs can repress the expression of Cx43 in gliomas, for instance, miRNAs 221-222 [14] . MiRNA-221 and miRNA-222, encoded in tandem on chromosome X, have frequently been found to be dysregulated in astrocytomas [15] .
One feature of miRNAs that highlights their relevance in cancer biology is the fact that each miRNA can target and downregulate the expression of several mRNAs to affect cell behavior. For instance, miRNAs 221-222 despite repressing Cx43, regulate important tumor-related proteins such as, p27, an important repressor of the progression through the cell cycle [16] , phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase (PTEN), a key regulator of cell growth and apoptosis and one of the most commonly altered tumor suppressors in gliomas and protein-tyrosine phosphatase μ (PTP μ), an important mediator of invasiveness [17] . Therefore, the synthesis of miRNAs 221-222 in one cell can reduce simultaneously the expression of Cx43, p27, PTEN and PTPμ, which are important tumor suppressor proteins, favoring tumoral transformation.
In addition, Cx43 is a target of miR-19a/b, which is part of the cluster miR17-92, a potential oncogene firstly described in lymphomas and thereafter in several other tumors including gliomas [18] . This cluster, located on human chromosome 13 (chromosome 14 in mice) encodes a polycistronic miRNA gene, which is matured into six functional miRNAs, miR-17, miR-18a, miR-19a, miR-19b, miR-20 and miR-92. Among them, miR-19a/b has shown to be overexpressed in gliomas and their expression correlates with malignancy [19] .
All together these data suggest that miRNAs could be involved in the downregulation of Cx43 protein found in high-grade gliomas. Downregulation mediated by miRNA is typically the consequence of imperfect base pairing of miRNAs with sequences in the 3'untraslated regions of target mRNAs. This causes inhibition of translation without mRNA degradation, and therefore could explain the lack of correlation between mRNA and protein levels of Cx43 found in some high-grade gliomas [20] . More importantly, miRNAs could be an interesting target for glioma therapy.
By scanning connexin mRNAs for seed sequences -i.e. for the conserved 5'-terminal regions of miRNAs that need to perfectly match the complementary sequence in the target mRNA for miRNAs to be effective -Previous studies [21] identified several potential regulatory miRNAs targeting human and murine Cx mRNAs. A few miRNAs were demonstrated to actually interact with connexin mRNAs and some even to control the expression of connexins. For example, there are hints for an involvement of miR-145 in the regulation of Cx43 expression in human corneal epithelial progenitor cells [22] , for the binding of miR-218 to the 3'-UTR of human Cx43 mRNA and for miR-208a to be required for expression of Cx40 [23] . However, the two best-explored miRNA regulators of connexin expression are miR-1 and miR-206.
MiR-1, a microRNA expressed in cardiac and skeletal muscle, was found upregulated in hearts of humans suffering from coronary artery disease, in rat hearts following an experimentally induced myocardial infarction or in cultured rat cardiomyocytes after ischemia/reperfusion [24] . Similarly, miR-1 was upregulated in a mouse model of viral myocarditis [25] . In all cases, miR-1 upregulation coincided with decreased levels of Cx43 and a dislocation of Cx43 gap junctions in heart tissue. In contrast, the downregulation of miR-1 was reported for patients with atrial fibrillation, with no changes in Cx43 levels or localization [26] , suggesting a complex network of miRNA-dependent regulation in the heart. The 3'-UTR of Cx43 (both human and rat) was then demonstrated to be a target of miR-1. Cx43 mRNA levels appear to be only marginally affected by miR-1, suggesting repression of Cx43 mRNA translation (rather than enhancing its degradation) as the mechanism of action of miR-1 [27] . It is unclear whether a loss in Cx43 is a major contributor to the above pathologies reported to come with an increase in miR-1 levels: it needs mentioning that other proteins equally well known to be involved in cardiac conduction are miR-1 targets as well, such as potassium and calcium channels [28] .
Like miR-1, miR-206, which is highly expressed in skeletal muscle, skin, lung and in osteoblasts binds to the 3'-UTR of Cx43 -both miRs share the same seed sequence, so they interact with the same two sequence elements identified in the 3'UTR of human Cx43 mRNA [29] . MiR-206 is an inhibitor of osteoblast differentiation: overexpression caused a downregulation of differentiation markers in cultured murine C1C12 cells and in vivo in a mouse model for osteoblast-specific miR-206 overexpression. In parallel, Cx43 was downregulated under these conditions. Interestingly, the effects of miR-206 overexpression were blunted by co-expression of Cx43, pointing to an involvement of Cx43 in osteoblast differentiation and its depletion contributing to the inhibitory effects of miR-206 on differentiation [30] . Parathyroid hormone effects on osteoblast differentiation and on Cx43 are likely not via modulation of miR-206 levels [31] . The levels of miR-206 also change during developmental processes in skeletal muscle. It is strongly upregulated in vivo in skeletal muscle of newborn vs. prenatal mice and in vitro in C2C12 cells post-vs. pre-differentiation, coinciding in both cases with a drastic decrease in Cx43 protein (but not mRNA) levels, which was partially prevented by depletion of miR-1 and -206 [32] . As with miR-1, Cx43 mRNA levels appear to not be affected by miR-206 levels, again suggesting translational repression as the mechanism of action of miR-206 in downregulating Cx43.
Connexin levels and function are affected during carcinogenesis, and cancer cells tend to a clear inverse relationship between miR-1/-206 and Cx43 expression, which would suggest that cancer cells derived from Cx43 expressing cells would tend to have elevated miR-1/-206 levels, the situation appears to be more complex than that: rather than elevated miR-1/-206 (which would be linked to a downregulation of Cx43), there two miRNAs are downregulated in many types of cancers, including cancers derived from cells expression Cx43 [33] . Such as apparent contradiction may be explained by the fact that carcinogenesis and CJIC are linked, but that this is not a monofactorial or unidirectional relationship: there are other factors contributing to carcinogenesis -and there are stages in carcinogenesis that may benefit from increased Cx levels and an enhanced GJIC, such as invasion and metastasis. For these reasons, connexins were recently characterized as conditional tumor suppressor [34] . miRNAs are able to regulate gap junction proteins which is critical for cardiac rhythm. For example, miR-1 was found to regulate Cx43 in murine models of myocardial infarction and myocarditis. Further studies indicated that Cx43 is a direct target of miR-19a/b [35] .
MicroRNA-130a has been implicated in the angiogenic process [36] . Osbourne et al. [37] found Cx43 is a direct target of miR-130a which suggests overexpression of miR-130a may result in the remodeling of gap junction and may lead to the pathogenesis of atrial and ventricular arrhythmias.
MicroRNAs can also act as positive regulator of connexin expression. In this light, miR-145 upregulates Cx43 production upon differentiation of human corneal epithelial progenitor cells [38] . Furthermore, microRNAs can indirectly affect connexin production. Thus, miR-103/107 directly targets the expression of receptor M type protein tyrosine phosphatase in limbal derived corneal epithelial cells, which in turns affects Cx43-based gap junctions [39] . Also, miR-200 regulates production of zinc finger E-box binding homeobox proteins 1 and 2, which transcriptionally repress Cx43 expression in human myometrial cells [40] . MiR-125b and miR221/222 promote cell cycling and/or invasion in glioma cell cultures, thereby suppressing Cx43 expression [41] . Likewise, miR-20a is highly expressed in human cancer cells and negatively affects Cx43 production [42] . Both miR-200a and miR-206 and miR-1 diminish Cx43 levels during experimentally induced alkali burn injury in mouse cornea and in chronic neuropathy in rat sciatic nerves, respectively.
It should be mentioned that the interaction between miRNAs and connexins can occur in both directions. Indeed, forced expression of Cx43 in glioma cell cultures antagonizes miR-125b-mediated cell growth [43] . On the other hand, silencing of Cx43 production reverses the protective effect of miR-206 downregulation in alkali-burned cornea [44] . Interestingly, besides acting as regulators of the production of their building stones, miRNAs can also permeate gap junctions. In this regard, miR-5096 is conveyed via gap junctions between glioma cells and as such exerts proinvasive effects [45] . Antiproliferative miR-124-3p travels through Cx43-based gap junctions in glioblastoma cells [46] . Gap junctions also transfer miR-210 in cocultures of mesenchymal stem cells and cardiomyocytes as well as miR-142 and miR-223 between macrophages and hepatocellular carcinoma cells [47] .
In conclusion, considering the enormous complexity of posttranscriptional regulation of gene expression that is currently emerging; only little is known on posttranscriptional control of connexin expression that goes beyond the mere fact that connexin expression is indeed controlled posttransriptonally under certain circumstances. Further identification of molecular mechanisms, (patho-) physiological significance of posttranscriptonal control and pharmacological modulators will yield valuable information that may be exploited in therapeutical approaches aiming at altering connexin expression and gap junctional communication-as indicated by the current findings on the role of RNA binding proteins, miRNAs in the control of Cx43 expression, which already offer various potential molecular targets.
